Molecular Templates Inc.

03/31/2023 | Press release | Distributed by Public on 03/31/2023 04:04

Announces strategic reprioritization to focus on clinical development of MT-6402, MT-8421, and MT-0169, and preclinical activities related to BMS collaboration, and related[...]

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.